// App-Quantinova.ai

E086 : Comparing ankylosing spondylitis disease activity during the COVID-19 pandemic using patient-reported outcome measures with face-to-face clinical evaluation of disease scores pre-pandemic

Researchers

Presenter

  • Dominik A Kurzeja

Principal Investigators

  • Kaiyang Song

  • Maria Mirza

  • Madiha Ashraf

  • Lija James

  • Ayna Verdiyeva

  • Raashid Luqmani

Medical Centers

  • Internal Medicine, Oxford University Hospitals, Oxford, United Kingdom

  • Ndorms, Nuffield Orthopaedic Centre, Oxford, United Kingdom

  • Rheumatology Department, Great Western Hospital, Swindon, United Kingdom

  • Medical School, University of Oxford, Oxford, United Kingdom

  • Department of Rheumatology,, Stoke Mandeville Hospital, Aylesbury, United Kingdom,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Musculoskeletal

Disease

  • Ankylosing spondylitis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final